Physician profile
Meghan M Murphy
NPI 1932304540
$29,453.60
in general payments reported to CMS, 2019-2025
20 companies · $3,847 in 2025
The $3,847 reported for 2025 was more than what 97% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,625 · 2022: $16K · 2023: $2,547 · 2024: $3,901 · 2025: $3,847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,295.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $14,916.54 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Abbott Laboratories | $8,507.79 | 2021-2025 | Gallant, Aveir, Assurity |
| Biosense Webster, INC. | $1,686.10 | 2021-2025 | Carto 3, Na |
| Pfizer INC. | $1,075.10 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $773.45 | 2021-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $769.77 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $632.92 | 2021-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Sanofi-Aventis U.S. LLC | $205.79 | 2021-2024 | |
| Cvrx, INC. | $199.68 | 2022-2023 | Barostim Neo System |
| Cardiva Medical, INC. | $108.55 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Abiomed | $105.75 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.86 | 2021-2023 | Lifevest |
| Vital Connect, INC | $79.92 | 2023-2024 | Vitalpatch Rtm |
| Irhythm Technologies, INC. | $69.25 | 2023-2024 | Zio Xt Patch, Zio At Patch, Zio Monitor |
| Medtronic, INC. | $69.03 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $45.50 | 2023 | Optimizer |
| Altathera Pharmaceuticals LLC | $37.03 | 2025 | Sotalol Hydrochloride |
| Alnylam Pharmaceuticals INC. | $29.45 | 2024 | Onpattro |
| Davol INC. | $28.73 | 2022 | |
| Convatec INC. | $12.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.